Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abcellera, Airway, Arctic Vision Shanghai, Athenex, Aytu, Biogen, Brii, Chembio Diagnostics, Clearside, Context, Correvio, Cytovance, Eli Lilly, Emergent Biosolutions, GT Biopharma, Hitgen, Hong Kong Teson, I-Mab, Immunoprecise Antibodies, Innovation, Kaken, Kamada, Kirin, La Jolla, Lattice, Lumiradx, Mallinckrodt, Medicago, Mesoblast, Nanoviricides, Nicox, Novavax, Ocumension, Olix, Oncosec, Pharmamar, Pluristem, Protalix, Qiagen, Roche, Sengenics, TFF, Tiziana Life Sciences, Twist, Tyligand, Vir, Xavier Saelens, Xortx, Zhejiang Orient Gene Biotech.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Biocure Pharm, Bristol Myers Squibb, Harbour Biomed, Life Sciences Partners, Otsuka, Quest Pharmatech, Tiziana Life Sciences.
The latest global regulatory news, changes and updates affecting biopharma, including: U.S. Trade Representative, World Trade Organization.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Moderna, Regeneron, Sanofi, Santen, Takeda, Tracon.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Cytodyn, Zai Lab.